Vanda Pharmaceuticals (VNDA) Current Deferred Revenue (2009 - 2014)
Vanda Pharmaceuticals (VNDA) reported Current Deferred Revenue of $174,000 for Q4 2014, down 99.4% from $26.79 million a year earlier and down 99.4% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Current Deferred Revenue (2009 - 2014) Analysis & Trends
Dating back to Q4 2010, Vanda Pharmaceuticals' Current Deferred Revenue record includes 16 quarters.
- Current Deferred Revenue has a four-year compound annual growth rate of -71.6% (FY2010 to FY2014).
- By year, Current Deferred Revenue came in at $26.79 million in FY2013 (unchanged), $26.79 million in FY2012 (unchanged), $26.79 million in FY2011 (unchanged) and $26.79 million in FY2010.
- The Q4 2014 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Year over year, Current Deferred Revenue gained in three of the last eight quarters, with an average decline of 6.4%.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2014 (growth of 16.6%); the low point was Q4 2014 (a decline of 99.4%).
- Per Business Quant data, the three quarters before Q4 2014 came in at $31.23 million (Q3 2014), $31.06 million (Q2 2014) and $31.06 million (Q1 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 174,000.00 |
| Sep 30, 2014 | 31.23 Mn |
| Jun 30, 2014 | 31.06 Mn |
| Mar 31, 2014 | 31.06 Mn |
| Dec 31, 2013 | 26.79 Mn |
| Sep 30, 2013 | 26.79 Mn |
| Jun 30, 2013 | 26.79 Mn |
| Mar 31, 2013 | 26.79 Mn |
| Dec 31, 2012 | 26.79 Mn |
| Sep 30, 2012 | 26.79 Mn |
| Jun 30, 2012 | 26.79 Mn |
| Mar 31, 2012 | 26.79 Mn |
| Dec 31, 2011 | 26.79 Mn |
| Sep 30, 2011 | 26.79 Mn |
| Jun 30, 2011 | 26.79 Mn |
| Mar 31, 2011 | 26.79 Mn |
| Dec 31, 2010 | 26.79 Mn |
| Sep 30, 2010 | 26.79 Mn |
| Jun 30, 2010 | 26.79 Mn |
| Mar 31, 2010 | 26.79 Mn |
API Access
Vanda Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();